The Discounted Cash Flow (DCF) valuation of MEI Pharma Inc (MEIP) is 4.95 USD. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on DCF is 61.2%.
Based on the latest price of 3.07 USD and our DCF valuation, MEI Pharma Inc (MEIP) is a buy. buying MEIP stocks now will result in a potential gain of 61.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.3% | 7.4% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 3.87 - 7.21 | 4.95 |
| Upside | 26.2% - 134.8% | 61.2% |